Clinical trial
The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in…
NCT00206947 · Birte Glenthoj, Other · Terminated
Key facts
| NCT number | NCT00206947 |
|---|---|
| Title | The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia |
| Official title | PHARMACOLOGICAL TREATMENT OF COGNITIVE DEFICITS IN SCHIZOPHRENIC PATIENTS: The Effects of Central Cholinergic Augmentation on Cognitive Deficits and Psychopathology |
| Lead sponsor | Birte Glenthoj, Other |
| Collaborators | Rigshospitalet, Denmark Glostrup University Hospital, Copenhagen Pfizer Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | donepezil (5-10 mg/day), Placebo |
| Enrollment | 50 |
| Start date | Dec 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 20, 2011 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: